Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


03.04.2017

1 Am J Epidemiol
1 BMC Neurol
1 Int J Neurosci
2 J Neural Transm (Vienna)
1 Lancet Neurol
2 Mov Disord
1 Nat Rev Neurol
2 Neurology
2 Neurosci Lett
3 PLoS One
2 Proc Natl Acad Sci U S A
1 Science


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Epidemiol

  1. LIU Z, Roosaar A, Axell T, Ye W, et al
    Tobacco Use, Oral Health, and Risk of Parkinson's Disease.
    Am J Epidemiol. 2017 Mar 9:1-8. doi: 10.1093.
    PubMed     Text format     Abstract available


    BMC Neurol

  2. OERTON E, Bender A
    Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson's disease: a comparison of 33 human and animal studies.
    BMC Neurol. 2017;17:58.
    PubMed     Text format     Abstract available


    Int J Neurosci

  3. PAHWA R, Lyons KE
    Outpatient titration of carbidopa/levodopa enteral suspension (Duopa).
    Int J Neurosci. 2017;127:459-465.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  4. BLESA J, Trigo-Damas I, Del Rey NL, Obeso JA, et al
    The use of nonhuman primate models to understand processes in Parkinson's disease.
    J Neural Transm (Vienna). 2017 Mar 29. doi: 10.1007/s00702-017-1715.
    PubMed     Text format     Abstract available

  5. KRUGER R, Klucken J, Weiss D, Tonges L, et al
    Classification of advanced stages of Parkinson's disease: translation into stratified treatments.
    J Neural Transm (Vienna). 2017 Mar 24. doi: 10.1007/s00702-017-1707.
    PubMed     Text format     Abstract available


    Lancet Neurol

  6. WILE DJ, Agarwal PA, Schulzer M, Mak E, et al
    Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
    Lancet Neurol. 2017 Mar 20. pii: S1474-4422(17)30056.
    PubMed     Text format     Abstract available


    Mov Disord

  7. BARICHELLA M, Cereda E, Cassani E, Frazzitta G, et al
    A focus on Rome III criteria for the assessment of constipation in Parkinson's disease.
    Mov Disord. 2017 Mar 25. doi: 10.1002/mds.26974.
    PubMed     Text format    

  8. XU T, Wang S, Lalchandani RR, Ding JB, et al
    Motor learning in animal models of Parkinson's disease: Aberrant synaptic plasticity in the motor cortex.
    Mov Disord. 2017 Mar 25. doi: 10.1002/mds.26938.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  9. FYFE I
    Movement disorders: Comparison of cognitive impairment in Parkinson disease and essential tremor.
    Nat Rev Neurol. 2017 Mar 24. doi: 10.1038/nrneurol.2017.
    PubMed     Text format    


    Neurology

  10. BENITO-LEON J
    Viral hepatitis and the risk of Parkinson disease.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003853.
    PubMed     Text format    

  11. PAKPOOR J, Noyce A, Goldacre R, Selkihova M, et al
    Viral hepatitis and Parkinson disease: A national record-linkage study.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003848.
    PubMed     Text format     Abstract available


    Neurosci Lett

  12. CHEN S, Liu Y, Niu Y, Xu Y, et al
    Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson's disease patients.
    Neurosci Lett. 2017 Mar 27. pii: S0304-3940(17)30275.
    PubMed     Text format     Abstract available

  13. KUMARI N, Agrawal S, Luthra PM
    Pharmacological assessments of potent A2A receptor antagonist IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo[4,5-d]pyrimidin-6(7H)-yl)urea) in rodent model of haloperidol induced Parkinson like symptoms.
    Neurosci Lett. 2017;647:53-60.
    PubMed     Text format     Abstract available


    PLoS One

  14. HUERTAS I, Jesus S, Lojo JA, Garcia-Gomez FJ, et al
    Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.
    PLoS One. 2017;12:e0174644.
    PubMed     Text format     Abstract available

  15. YAN H, Wang J
    Quantification of motor network dynamics in Parkinson's disease by means of landscape and flux theory.
    PLoS One. 2017;12:e0174364.
    PubMed     Text format     Abstract available

  16. BLOCK VA, Pitsch E, Tahir P, Cree BA, et al
    Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
    PLoS One. 2016;11:e0154335.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  17. KIM KS
    Toward neuroprotective treatments of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2017 Mar 30. pii: 201703362.
    PubMed     Text format    

  18. SPATHIS AD, Asvos X, Ziavra D, Karampelas T, et al
    Nurr1:RXRalpha heterodimer activation as monotherapy for Parkinson's disease.
    Proc Natl Acad Sci U S A. 2017 Mar 27. pii: 201616874.
    PubMed     Text format     Abstract available


    Science

  19. MAO X, Ou MT, Karuppagounder SS, Kam TI, et al
    Pathological alpha-synuclein transmission initiated by binding lymphocyte-activation gene 3.
    Science. 2016;353.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: